Imatinib-induced Extensive Hyperpigmentation in a Case of Chronic Myeloid Leukemia

Imatinib, a tyrosine kinase inhibitor, is well known to cause hypopigmentation because of its inhibitory effect on melanocytes. Herewith we report a case of chronic myeloid leukemia who developed extensive hyperpigmentation following imatinib therapy.

Detalles Bibliográficos
Autores principales: Balasubramanian, Pradeep, Jagadeesan, Soumya, Thomas, Jacob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
E-IJD Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4601460/
https://www.ncbi.nlm.nih.gov/pubmed/26538739
http://dx.doi.org/10.4103/0019-5154.164447
_version_ 1782394556265791488
author Balasubramanian, Pradeep
Jagadeesan, Soumya
Thomas, Jacob
author_facet Balasubramanian, Pradeep
Jagadeesan, Soumya
Thomas, Jacob
author_sort Balasubramanian, Pradeep
collection PubMed
description Imatinib, a tyrosine kinase inhibitor, is well known to cause hypopigmentation because of its inhibitory effect on melanocytes. Herewith we report a case of chronic myeloid leukemia who developed extensive hyperpigmentation following imatinib therapy.
format Online
Article
Text
id pubmed-4601460
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-46014602015-11-04 Imatinib-induced Extensive Hyperpigmentation in a Case of Chronic Myeloid Leukemia Balasubramanian, Pradeep Jagadeesan, Soumya Thomas, Jacob Indian J Dermatol E-IJD Case Report Imatinib, a tyrosine kinase inhibitor, is well known to cause hypopigmentation because of its inhibitory effect on melanocytes. Herewith we report a case of chronic myeloid leukemia who developed extensive hyperpigmentation following imatinib therapy. Medknow Publications & Media Pvt Ltd 2015 /pmc/articles/PMC4601460/ /pubmed/26538739 http://dx.doi.org/10.4103/0019-5154.164447 Text en Copyright: © Indian Journal of Dermatology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle E-IJD Case Report
Balasubramanian, Pradeep
Jagadeesan, Soumya
Thomas, Jacob
Imatinib-induced Extensive Hyperpigmentation in a Case of Chronic Myeloid Leukemia
title Imatinib-induced Extensive Hyperpigmentation in a Case of Chronic Myeloid Leukemia
title_full Imatinib-induced Extensive Hyperpigmentation in a Case of Chronic Myeloid Leukemia
title_fullStr Imatinib-induced Extensive Hyperpigmentation in a Case of Chronic Myeloid Leukemia
title_full_unstemmed Imatinib-induced Extensive Hyperpigmentation in a Case of Chronic Myeloid Leukemia
title_short Imatinib-induced Extensive Hyperpigmentation in a Case of Chronic Myeloid Leukemia
title_sort imatinib-induced extensive hyperpigmentation in a case of chronic myeloid leukemia
topic E-IJD Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4601460/
https://www.ncbi.nlm.nih.gov/pubmed/26538739
http://dx.doi.org/10.4103/0019-5154.164447
work_keys_str_mv AT balasubramanianpradeep imatinibinducedextensivehyperpigmentationinacaseofchronicmyeloidleukemia
AT jagadeesansoumya imatinibinducedextensivehyperpigmentationinacaseofchronicmyeloidleukemia
AT thomasjacob imatinibinducedextensivehyperpigmentationinacaseofchronicmyeloidleukemia

Ejemplares similares